Background: Canine cardiovascular problems are commonly seen in veterinary medicine. Cardiac abnormalities in canine can be diagnosed by various means like electrochardiography, radiography, blood pressure measurement, echocardiography and biomarkers like troponins and peptides specific for heart....
Author(s)
Mahendran, K.; Neeraj Thakur; Chethan, G. E.; Priyanka; Choudhary, S. S.; Dey, S.; Saxena, A. C.; Sumit Mahajan; Kavitha, K.
Publisher
Agricultural Research Communication Centre, Karnal, India
Citation
Indian Journal of Animal Research, 2022, 56, 2, pp 234-238
Introduction: An important aspect of heart failure is the progressive ineffectiveness of the salutary natriuretic peptide system and its secondary messenger, 3′,5′-cyclic guanosine monophosphate (cGMP). In humans with acute heart failure, administration of exogenous natriuretic peptide is...
Author(s)
Oyama, M. A.; Solter, P. F.; Thorn, C. L.; Stern, J. A.
Publisher
Elsevier Ltd, Oxford, UK
Citation
Journal of Veterinary Cardiology, 2017, 19, 3, pp 211-217
Background: N-terminal pro-brain natriuretic peptide (NT-proBNP) is a widely used point-of-care (POC) cardiac biomarker in human medicine. Canine NT-proBNP is used less in veterinary medicine, possibly due to the lack of a POC canine NT-proBNP assay resulting in temporal delay, increased...
Author(s)
Harr, K. E.; Gordon, S. G.; Baumwart, R. D.; Feldgreber, R.; Spiro, M. R.
Publisher
Wiley, Boston, USA
Citation
Veterinary Clinical Pathology, 2022, 51, 3, pp 398-407
This study investigated the direct effects of non-steroidal anti-inflammatory drugs (NSAIDs) and atrial natriuretic peptide (ANP) on canine-derived vascular endothelial cells (VECs). VECs were isolated and cultured from canine arteries and veins. The mRNA expressions of vascular endothelial growth...
Author(s)
Horikirizono, H.; Ishigaki, K.; Amaha, T.; Iizuka, K.; Nagumo, T.; Tamura, K.; Seki, M.; Edamura, K.; Asano, K.
Publisher
Japanese Society of Veterinary Science, Tokyo, Japan
Citation
Journal of Veterinary Medical Science, 2019, 81, 5, pp 776-779
N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) is a potential cardiac biomarker released primarily from ventricular myocytes. Previous studies in dogs suggest that the NT-proBNP assay can be used to distinguish dogs with respiratory signs between congestive heart failure and primary...
Author(s)
Riengvirodkij, N.; Sakcamduang, W.
Publisher
Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, Thailand
Citation
Journal of Applied Animal Science, 2021, 14, 2, pp 9-20
The clinical utility of plasma natriuretic peptide concentrations in dogs with right-sided congestive heart failure (CHF) remains unclear. We investigated whether plasma levels of atrial natriuretic peptide (ANP) and N-terminal pro B-type natriuretic peptide (NT-proBNP) are useful for assessing the ...
Author(s)
Kanno, N.; Hori, Y.; Hidaka, Y.; Chikazawa, S.; Kanai, K.; Hoshi, F.; Itoh, N.
Publisher
Japanese Society of Veterinary Science, Tokyo, Japan
Citation
Journal of Veterinary Medical Science, 2016, 78, 4, pp 535-542
We examined the immunohistochemical distributions of natriuretic peptide receptor (NPR)-A, -B and -C that bind with natriuretic peptide hormones A, B and C in four healthy crossbreed young canine and feline cardiac tissues using specific antibodies against human antigens. Cross-immunoreactivities...
Author(s)
Yamane, T.; Takemura, N.; Inoue, H.; Soeta, S.; Oishi, M.; Amasaki, H.
Publisher
Japanese Society of Veterinary Science, Tokyo, Japan
Citation
Journal of Veterinary Medical Science, 2011, 73, 3, pp 375-378
Background: There is no agreement in current publications regarding the reliability of serum concentrations of natriuretic peptides (NPs) to detect dogs with subclinical myxomatous mitral valve disease (MMVD) and to differentiate between asymptomatic stages. Objectives: We sought to compare...
Author(s)
Wolf, J.; Gerlach, N.; Weber, K.; Klima, A.; Wess, G.
Publisher
Wiley-Blackwell, Boston, USA
Citation
Veterinary Clinical Pathology, 2013, 42, 2, pp 196-206
Measurement of N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels has been shown to have clinical significance for diagnosis and management of heart disease in dogs. Evaluation of current reference limits for specific breeds is necessary to ensure the test can accurately distinguish...
Author(s)
Brennan, C.; Gunasekaran, T.; Sanders, R. A.
Publisher
Public Library of Sciences (PLoS), San Francisco, USA
Citation
PLoS ONE, 2022, 17, 1,
We aimed to evaluate the utility and sex dependence of serum N-terminal pro-brain natriuretic peptide (NT-proBNP concentration) as a predictor of survival and treatment response in dogs with heart failure. We hypothesized that the serial trend of NT-proBNP levels would be predictive of outcomes and ...
Author(s)
Chan, I. P.; Hsueh, T.; Chang, C. C.; Chen, W. Y.
Publisher
Faculty of Veterinary Science, University of Agriculture, Faisalabad, Pakistan
Citation
Pakistan Veterinary Journal, 2019, 39, 3, pp 347-352